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Abstract – The recovery period following cortical injury (CI) is characterized by a dynamic and highly complex interplay 
between beneficial and detrimental events. The aim of this study was to examine the expressions of Glial Fibrillary Acidic 
Protein (GFAP), Apolipoprotein E (ApoE) and Amyloid Precursor Protein (APP), all of which are involved in brain plas-
ticity and neurodegeneration. Our results reveal that CI strongly influenced GFAP, ApoE and APP mRNA expression, as 
well as GFAP and ApoE protein expression. Considering the pivotal role of these proteins in the brain, the obtained results 
point to their potential contribution in neurodegeneration and consequent Alzheimer’s disease development.
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INTRODUCTION
Traumatic brain injury (TBI) is a leading cause of 
death and disability. It is responsible for severe neu-
rostructural damage and impairment of neurologi-
cal functions. TBI shows many of the neuropatho-
logical characteristics of Alzheimer’s disease (AD), 
including diffuse β-amyloid precursor protein (Aβ) 
plaques, neurofibrillary tangles and acetylcholine 
deficiency (Ikonomovic et al., 2004). Long-term dis-
abilities resulting from TBI depend on the severity 
of the injury, location, age and general health of an 
individual. Recovery after TBI is varied and not fully 
explained by prognostic features, suggesting that ad-
ditional factors modulate secondary injury and re-
covery (Masel and DeWitt, 2010). 
Astrocytes are the most abundant glial cell type. 
They are dispersed throughout the brain tissue and 
they make essential contributions to many homeo-
static functions that could directly influence neuronal 
survival and functional outcome after TBI. It has been 
established that astrocytes play a role in modulating 
neuron signaling (Volterra and Meldolesi, 2005). As-
trocytes respond to injury by increasing the expression 
of the specific cellular marker GFAP by changing their 
cell surface and secreted molecules and by altering 
their morphology (Chen and Swanson, 2003; Middel-
dorp and Hol, 2011). There are pronounced changes 
in astrocyte morphology, as is shown by the upregu-
lation of GFAP in the astrocytes around the injured 
site (Pekny and Pekna, 2004). They participate in glial 
scar formation and display both growth-promoting 
and growth-inhibiting properties in axon regenera-
tion (Fawcett and Asher, 1999; Myer, et al. 2006).  
Apolipoprotein E (ApoE) is a multifunctional 
protein with an expanding role in the neurobiology of 
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disease. Although originally described in the context 
of cholesterol metabolism, interest in the neurobiol-
ogy of ApoE has intensified following the association 
between the ApoE genotype and the risk of develop-
ing Alzheimer’s disease. Recent clinical observations 
also suggest that the ApoE genotype may influence 
recovery after a variety of neurological insults. ApoE 
distributes cholesterol and phospholipids to neurons 
after injury and is therefore an important mediator 
of the CNS response to brain injury (Hauser et al., 
2011). In normal rodent brain, ApoE immunore-
activity is largely confined to astrocytes (Laskowitz 
et al., 1998; Smiljanic et al. 2010). After injury, its 
expression dramatically increases in both glial and 
neuronal cells. It has been shown that ApoE influ-
ences pivotal processes in the brain, such as neuronal 
repair, regeneration and survival (Horsburgh et al., 
2000; White et al. 2001; Iwata et al., 2005). Although 
the neurobiology of ApoE in the injured brain re-
mains incompletely defined, there is evidence to sug-
gest neurotrophic, immunomodulatory and antioxi-
dant effects. Considering all the important roles of 
ApoE listed above, one can assume that even small 
changes in the expression of this protein could have 
profound consequences.
Amyloid precursor protein (APP) is an integral 
membrane glycoprotein that is ubiquitously ex-
pressed and serves as a sensitive marker of axonal 
injury but may also have an important function fol-
lowing TBI (Selkoe et al. 1988; Bramlett et al. 1997). 
In the brain, APP is synthesized in the neuronal cell 
body. Following synthesis, APP undergoes rapid ax-
onal transport and is targeted to synaptic sites, where 
can be detected in synaptic membranes (Card et al. 
1988). Although the physiological role of APP in the 
brain is still unclear, studies have suggested a range 
of cellular functions for APP, including roles in neu-
roprotection, neurite outgrowth, synaptogenesis and 
synaptic plasticity (Van den Heuvel et al. 1999). APP 
is upregulated in injured neurons and reactive astro-
cytes following TBI, and this upregulation has been 
associated with increased Aβ peptide, the risk factor 
for the development of AD. Aβ peptide is a major 
constituent of senile plaques found in the brains of 
patients suffering from AD (Stephenson et al., 1992).
The clinical outcome after neurotrauma is con-
siderably variable and can only partly be explained 
by known prognostic factors. There is converging 
evidence from genetic research that a number of ge-
netic variants may contribute to this variability. Con-
sidering the pivotal roles of GFAP, ApoE and APP 
in regeneration and neurodegeneration in the CNS, 
the aim of this study was to examine the temporal 
alterations of their mRNA and protein levels in the 
ipsilateral cortex following cortical stab injury.
MATERIALS AND METHODS
Animals
A cohort of 55 adult male Wistar rats (6 months old; 
300-350 g) was used. The animals were housed under 
standard conditions (23±2°C, 60-70% relative hu-
midity, 12 h light/dark cycles (lights were switched 
on at 07:00); free access to food and water; n = 3 per 
cage) in the Institute for Biological Research, Bel-
grade. All the animal procedures were approved by 
the Committee for Ethical Animal Care and Use of 
the Institute for Biological Research, Belgrade, which 
acts in accordance with the Guide for the Care and 
Use of Laboratory Animals, published by the U.S. 
National Institute of Health (NIH Publication No. 
85/23, revised in 1986).
Surgery
The animals were anesthetized with Nembutal (50 
mg/kg, Serva), placed into a stereotaxic frame and 
their scalps shaved. An incision was made along the 
midline of the scalp and the bregma was exposed. 
Cortical focal injuries were performed unilaterally 
using a 1 mm-wide dental drill through the left so-
matosensory cortex. The drill was inserted 2 mm 
below the underlying cortical region. Lesions were 
performed in a triangular-shaped formation as 
previously described (Loncarevic-Vasiljkovic et al. 
2009). After surgery, the animals were kept in isola-
tion for 3 h until complete recovery from the an-
esthesia, and subsequently returned to their home 
cages in order to avoid social isolation stress (n= 3 
per cage).
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Experimental procedure
The animals were randomly divided into five groups 
(n = 11 per group). Physiological controls (desig-
nated as C) were decapitated without any treatment. 
The other animals were subjected to the surgery and 
groups were formed according to the times of the re-
covery period, at the end of which the animals were 
decapitated (after 2, 7, 14 and 28 days). 
RNA isolation
Total RNA from pooled ipsilateral cortical tissues 
(n = 4 animals per each time point were examined) 
was isolated using Trizol reagent. The tissue samples 
were homogenized in Trizol reagent (Invitrogen) at 
a ratio of 1 ml Trizol:0.1 g tissue, and total RNA was 
prepared according to the manufacturer’s instruc-
tions. RNA integrity was assessed by electrophoresis 
in 1% agarose gels. RNA concentrations were meas-
ured and calculated after spectrophotometry. Total 
RNA was treated with 10 U of RNase-free DNase I 
(Fermentas) and dissolved in diethylpyrocarbonate 
(DEPC)-treated water, according to the manufac-
turer’s protocol.
Reverse transcription (RT)
The RT reactions were performed in 20 μl with a 
High-Capacity cDNA Archive Kit (Applied Biosys-
tems, Foster City, CA) according to the manufac-
turer’s instructions. The reactions were carried out 
under RNase-free conditions at 25°C for 10 min, and 
at 37°C for 2 h. Each RT reaction was accompanied 
by an RT control in which the reverse transcriptase 
was replaced by DEPC-treated water. The cDNA was 
stored at -20°C until further use.
Real-time RT-PCR
TaqMan PCR reactions were performed with Assay-
on-Demand Gene Expression Products (Applied 
Biosystems) for ApoE (Assay ID Rn00593680_m1), 
APP (Assay ID Rn00570673_m1), and GFAP (As-
say ID Rn00566603_m1). The gene expression as-
say contained primers for amplification of the tar-
get gene and TaqMan MGB (minor groove binder) 
probe 6-FAM dye-labeled for the quantification step. 
Reactions were performed in a 25 μl reaction mixture 
containing 1×TaqMan Universal Master Mix with 
AmpErase UNG, 1×Assay Mix (Applied Biosystems) 
and the cDNA template (10 ng of RNA converted to 
cDNA). PCR reactions were carried out in the ABI 
Prism 7000 Sequence Detection System at 50°C for 
2 min, at 95°C for 10 min, followed by 40 cycles at 
95°C for 15 s and at 60°C for 1 min. The experimental 
threshold was calculated from the mean baseline flu-
orescence signal from cycles 3 to 15, plus 10 standard 
deviations. The point at which the amplification plot 
crosses this threshold is defined as Ct, which repre-
sents the cycle number at this point and is inversely 
proportional to the number of target copies present 
in the initial sample. Each sample was run in tripli-
cate and a mean value of each Ct triplicate was used 
for further calculation. A reference, an endogenous 
control, was included in every analysis to correct the 
differences in inter-assay amplification efficiency, 
and the expression of each gene was normalized to 
GAPDH (glyceraldehyde-3-phosphate dehydroge-
nase) expression. For the quantification, validation 
experiments were performed as described previously 
(Tanic et al. 2007). Quantification was performed by 
the 2-ΔΔCt method. The obtained results were ana-
lyzed by RQ Study Add ON software for the 7000 v 
1.1 SDS instrument (ABI Prism Sequence Detection 
System) with a confidence level of 95% (pb 0.05). For 
the assessment of the effects of cortical injury on the 
recovery period (2-28 days), the fold-change in the 
mRNA level was expressed relative to the calibrator; 
day 0 was taken as a control value (100%).
Western blot analysis
For Western blot analysis, the rats were killed by 
rapid decapitation. The brains were removed and the 
ipsilateral cortex was collected (n = 4 animals per 
each time point examined). The tissue was homog-
enized with a Dounce homogenizer in 10 vol (w/v) 
of RIPA buffer (50 mM Tris-Cl, pH 7.5, 150mM-
NaCl, 1% NP-40, 0.1% SDS, 10mMEDTA, pH 8.0, 
10mMEGTA, pH 7.2, 0.5% Triton X-100), followed 
by centrifugation (21,000×g, 30 min, 4°C), and the 
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supernatant was collected. Protein concentrations 
were determined using a Micro BCA Protein As-
say Kit (Pierce Biotechnology). Equal amounts of 
proteins (20 μg per lane) were loaded and separated 
by 10% SDS-PAGE and blotted onto nitrocellulose 
membranes (Amersham Bioscience). The mem-
branes were blocked at room temperature for 1 h 
in 5% non-fat dry milk in Tris-buffered saline/0.1% 
Tween 20 (TBST). The membranes were incubated 
either with mouse anti-APP (22C11) (1:750, Chemi-
con rabbit anti-GFAP (1:2000, DAKO) or rabbit 
anti-ApoE (1:500, Biodesign) antibodies for 1 h at 
room temperature in 5% non-fat dry milk/TBST. 
The membranes were incubated with the HRP-
labeled secondary anti-rabbit antibody (1:8000, 
ICN) or HRP-labeled secondary anti-mouse an-
tibody (1:2000, Sigma) in TBST for 1 h at room 
temperature. Three subsequent washes with 0.1% 
TBST were performed between each step. Each blot 
was subsequently re-probed with rabbit anti-actin 
antibody (1:8000, Sigma) that served as an endog-
enous control. The signal was detected by enhanced 
chemiluminescence (ECL, Amersham Bioscience) 
and subsequent exposure on X-ray film. All films 
were analyzed by densitometry using the computer-
ized image analysis program ImageQuant 5.0.
Immunohistochemical analysis
Rat brains for immunohistochemical analysis (n= 3 
per group) were fixed in 4% paraformaldehyde for 24 
h at 4°C and cryoprotected in a sucrose gradient (10-
30%) in 0.01 M PBS (in each percentage of sucrose 
for 24 h in 4°C). The brains were frozen in isopen-
tane on dry ice and stored at -70°C. Every fifth coro-
nal section (18 μm thick) through the site of injury 
was mounted on a slide, allowed to dry overnight 
and stored at -20°C. Before the immune reaction, the 
sections were rinsed in 0.01 M PBS and treated with 
0.3% hydrogen peroxide in methanol for 30 min at 
room temperature to block endogenous peroxidase. 
Three washes with 0.01 M PBS were performed be-
tween every step. Sections were immunostained 
with rabbit anti-GFAP antibody (1:2000, DAKO) in 
0.1% Triton X-100/0.01 M PBS at 4°C overnight and 
washed. The immunoreactive signal was developed 
with the avidin-biotin-peroxidase complex (ABC kit, 
Dako) using DAB as a chromogen. Sections were cov-
er-slipped and analyzed under a Leica (Leitz DMRB) 
microscope. A negative control slide for each tissue 
was incubated with non-immunized horse serum to 
replace the primary antibody.
Cresyl violet staining
Several coronal sections were also stained with the 
cellular stain cresyl violet to confirm typical neuro-
nal and glial morphology. Briefly, the sections were 
incubated in 0.1% cresyl violet acetate (Sigma) for 15 
min, rinsed in water for 5 min and dehydrated first in 
95% and then in 100% ethanol, and observed under 
a light microscope.
Statistical analysis
Significant differences between the sets of data were 
determined using STATISTICA software, version 
6.0, StatSoft. The relative changes in mRNA and 
protein levels are presented as percentages (mean ± 
SEM) of the control samples that were assumed to 
be 100%. Further statistical analysis was made with 
relative values. The data were analyzed by one-way 
analysis of variance (ANOVA), time after the injury 
as factor. Post hoc comparisons were performed with 
the Fisher LSD test. Statistical significance was set at 
p<0.05.
RESULTS
Lesion evaluation
The size of the lesion on the left unilateral cortex was 
assessed histologically by cresyl violet histological 
staining (Fig. 1). Apart from the lesion site, the other 
cortical regions did not exhibit any signs of damage. 
Typical neuronal polygonal morphology and astro-
glial cells with small, round and intensely-staining 
nuclei were verified by cresyl violet staining. 
GFAP mRNA and protein levels
Cortical injury induced significant changes in GFAP 
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expression on both the mRNA and protein level in 
the ipsilateral cortex during recovery (Fig. 2A, B). 
The most prominent increase in the level of GFAP 
mRNA was observed on the 2nd and 7th days (5.6- to 
4.7- fold, respectively), revealed by real time PCR 
(Fig. 2 A). Thereafter the mRNA declined progres-
sively but remained above the control level. To ex-
amine whether the cortical injury affected the level 
of GFAP protein expression, we performed Western 
blot analysis (Fig. 2 B). One-way ANOVA revealed 
a significant effect of time after the injury as a fac-
tor (F(4, 20) = 27.046, p = 0.000). Compared to the 
control group, a significant increase in the content 
of GFAP protein was detected during days 2-14 after 
the injury (*p<0.05). By the 28th day, it returned to 
the control level. 
To verify GFAP protein expression, we also per-
formed an immunohistochemical analysis (Fig. 3). 
As expected, intense astroglial activation was detect-
ed around the injury site throughout the recovery 
period, with the most pronounced morphological 
changes observed on the 7th day after the injury (Fig 
3B) compared to the control (Fig. 3A). The changes 
in astrocyte morphology pointed to the induction 
of reactive astrogliosis. By the 28th day of recovery, 
a glial scar was formed around the lesion site (Fig. 
3C). The reactive astrocytes had enlarged cell bodies, 
Fig. 1. Cresyl violet staining of the left ipsilateral cortex on the 
2nd day after injury. The arrows show the size and localization of 
the cortical lesion that is surrounded by degenerating neurons 
with very dense nuclei.
Fig. 2. (A) Expression of GFAP mRNA in the rat ipsilateral 
cortex following cortical focal injury, as revealed by Real-Time 
RT-PCR. (B) Expression of GFAP protein in the rat ipsilateral 
cortex following cortical focal injury. The results were obtained 
by Western blot analysis. The graph is accompanied by a repre-
sentative immunoblot. *p<0.05 vs. control. 
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with many very thick processes that branched in all 
directions, forming a dense net. 
ApoE mRNA and protein levels
Real time PCR and Western blot analysis were also 
performed to examine the changes in levels of ApoE 
mRNA and protein expression during days 2-28 after 
the cortical lesion (Fig. 4A). Significant changes (40-
50%) were observed in ApoE mRNA levels (2nd 7th 
and 14th days) in comparison to the matching con-
trol.
Significant changes in ApoE protein levels in the 
ipsilateral cortex after the lesion were also observed 
(Fig. 4B). One-way ANOVA revealed the significant 
effect of time after injury as a factor (F(4, 20)=13.62, 
p=0.000). In comparison with the control group, the 
level of ApoE protein was significantly increased on 
the 2nd and 7th days after the injury (*p<0.05).
APP mRNA and protein levels
 Changes in APP mRNA and protein levels 
after the injury are presented in Fig. 5. The expres-
sion of APP mRNA in the cortex was significantly 
decreased (by 20-35%) on the 2nd, 7th and 14th days 
after the lesion. Statistical analysis of the results ob-
tained by Western blot analysis did not reveal sig-
nificant changes in APP protein expression after the 
injury (Fig. 5B).
DISCUSSION
In the present study, we extended our previous in-
vestigations (Smiljanic et al., 2010) and examined 
the effect of cortical injury on the GFAP, ApoE and 
APP mRNA and protein levels during recovery af-
ter cortical insult. These gene products are involved 
in brain plasticity as well as in neurodegeneration 
(Arendt T., 2003). We examined the process of re-
Fig. 3. GFAP immunostaining following cortical focal injury. Top row: representative images of GFAP immunostaining 2.5x magnifica-
tion. Bottom row: representative images of GFAP immunostaining at 40x magnification. Scale bar for top row – 500 μm. Scale bar for 
bottom row – 40 μm.
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covery from the 2nd to the 28th day after injury since 
it covers the time of onset of axonal/terminal sprout-
ing and the appearance of synaptogenesis. Our result 
is consistent with extensive literature and supports 
the hypothesis that a widespread glial reaction, as 
shown by GFAP immunopositive astrocytes, is con-
siderably pronounced at the site of injury after 7 days 
of recovery (Sofroniew, 2009; Allmann et al., 2011). 
The fact that the observed astrocytes had enlarged 
cell bodies with numerous thick processes indicates 
that these cells are highly activated. By the 28th day of 
recovery, the activated astrocytes participated in the 
formation of the glial scar around the lesion site. The 
formation of a glial scar is a classic example of the 
complex interplay existing between neuroprotective 
and neurotoxic processes associated with reactive 
gliosis (Fawcett and Asher, 1999; Chen and Swan-
son, 2003). Reactive astrocytes release a wide array 
of mediators, including pro- and anti-inflammatory 
cytokines, neurotrophic factors, complement factors, 
reactive oxygen species (ROS), all of which poten-
tially mediate neuroprotective and/or neurotoxic 
effects. However, although it has been shown that 
reactive astrocytes protect neurons from inflamma-
tory processes after mild or moderate cortical injury 
(Sofroniew, 2009), it has also been documented that 
astroglial activation can have detrimental effects as 
well (Cafferty et al., 2007; Rolls et al., 2009). Namely, 
astroglial activation and increased GFAP expression 
are directly involved in the inhibition of axonal re-
growth and regeneration (Pekny et al., 1999; Menet 
et al.,, 2003; Wilhelmsson et al., 2004). Considering 
that neuroregeneration, axonal regrowth and synap-
togenesis are essential factors for successful recovery 
following injury, disruption of these processes could 
lead to neuropathology and neurodegeneration. In 
this context, the activation of astrocytes and exces-
sive GFAP production described in the present study 
could lead to some neuropathology in the later time 
points.
Our study has also demonstrated that the up-
regulation of GFAP protein in the ipsilateral cortex 
was in fine correlation with ApoE protein expres-
sion on the 2nd and 7th day following injury. Unlike 
the protein, ApoE mRNA expression markedly de-
clined from 2nd to 14th day following cortical injury; 
return to control level was achieved on day 28. The 
observed discrepancy between mRNA and pro-
tein levels could be due to post-transcriptional and 
post-translational mechanisms, which have been 
shown to temporally and spatially uncouple the ac-
Fig. 4. (A) Expression of ApoE mRNA in the rat ipsilateral 
cortex following cortical focal injury, as revealed by Real-Time 
RT-PCR. (B) Expression of ApoE protein in the rat ipsilateral 
cortex following cortical focal injury. The results were obtained 
by Western blot analysis. The graph is accompanied by a repre-
sentative immunoblot. *p<0.05 vs. control. 
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cumulation of mRNA and corresponding proteins 
(Petersen et al., 1999; Eastwood et al., 2006; Iwata 
et al., 2005). ApoE has a major role in lipid redis-
tribution, which is important for membrane main-
tenance and repair in the brain, and in the regula-
tion of synaptic remodeling following brain injury 
(Mahley RW, 1988; Poirier et al, 1993; Poirier et al, 
1994; Horsburgh et al., 2000). Deregulated lipid 
metabolism may be of particular importance for 
CNS injuries and disorders, as this organ has the 
highest lipid concentration next to adipose tissue. 
It has also been hypothesized that the ApoE protein 
is involved in the clearance and redistribution of li-
pid and cholesterol debris from the site of injury for 
reutilization, and that it plays an important func-
tion in long-term alterations in plasticity follow-
ing cortical injury (Horsburgh et al., 2000). Taking 
into account all essential processes in the cell that 
include ApoE, the upregulation of this protein ob-
served in early time points following injury may in-
dicate to its positive role in lipid redistribution and 
synaptic remodeling following injury. Considering 
that the upregulation of ApoE per se is not sufficient 
to claim that it is either a positive or negative event 
in the brain following injury, further investigations 
are necessary. 
In the present study, APP mRNA and protein 
expression were also examined. The APP mRNA 
level was decreased (~35%) on the 2nd and 7th day 
and the lower level persisted until the 14th day af-
ter injury. Full recovery was not achieved after 28 
days. However, the fact that there was no change in 
the APP protein level during recovery after corti-
cal injury might point to one of two possibilities. 
Firstly, it could be due to the plastic properties of 
the brain that are capable of maintaining APP lev-
els at the control level. Considering that it has been 
proposed that upregulation of APP is associated 
with increased Aβ peptide, the risk factor for the 
development of AD (Stephenson et al.,1992), and 
several other cerebral disorders (Zhang et al., 2011), 
the obtained result could mean that the brain itself 
is plastic enough to regulate a potentially detrimen-
tal protein following insult. Secondly, it might be 
due to the relatively short recovery period used in 
our experiment. Thus, there is a possibility that we 
are unaware of potential APP deregulations simply 
because they occur in later in time. 
It was recently shown that alterations of choles-
terol homeostasis in the brain by exogenous admin-
istration of dietary cholesterol, or through inhibi-
tion of cholesterol synthesis, markedly affect beta 
amyloid production and deposition and significant-
Fig. 5. (A) Expression of APP mRNA in the rat ipsilateral cortex 
following cortical focal injury, as revealed by Real-Time RT-PCR. 
(B) Expression of APP protein in the rat ipsilateral cortex follow-
ing cortical focal injury. The results were obtained by Western 
blot analysis. The graph is accompanied by a representative im-
munoblot. *p<0.05 vs. control. 
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ly impair APP metabolism. It has been suggested 
that lipid homeostasis is controlled largely by the 
ApoE lipoprotein transport system in the extracel-
lular space, whereas alterations in intracellular lipid 
homeostasis markedly affect APP processing, beta 
amyloid production and plaque formation in vivo. 
Convergence of the so-called amyloid cascade hy-
pothesis and of the ApoE/lipid recycling cascade 
model is consistent with the notion that alterations 
in lipid homeostasis could serve as the common 
denominator for ApoE and beta amyloid dysfunc-
tions in Alzheimer’s disease (Poirier, 1994). It is 
also interesting to note that lipid homeostasis is a 
central feature of one of the most important neuro-
transmitter systems in thebrain, the cholinergic sys-
tem. This system is unique in the CNS since it relies 
heavily on lipid bioavailability to locally synthesize 
acetylcholine. It is thus quite tempting to propose 
that two of the most common neuropathological 
landmarks of AD – namely, cholinergic dysfunction 
and amyloid deposition, may in fact depend on the 
integrity of local lipid homeostatic processes, which 
in turn are strongly dependent upon proper lipid 
delivery by the ApoE transport system.
Taken together, our findings highlight the com-
plexity and heterogeneity of the molecular and cellu-
lar responses to cortical injury. Although our results 
showed that cortical injury affected GFAP, ApoE and 
APP mRNAs and protein expression, we can only 
hypothesize whether the observed changes have ben-
eficial or detrimental consequences upon brain func-
tioning. Further investigations are needed in order to 
answer this question.
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